Lumasag, Lienne .

HRN: 26-80-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/11/2026
08/18/2026
IV
300mg
Q6
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines